Providence, Rhode Island 02912

  • Stress, Psychological

Purpose:

MB-College (MBC) is an 9-week, 9 session program (i.e., the study intervention being tested in the RCT) providing systematic and intensive training in mindfulness meditation practices, applied to health behaviors relevant to college students and young adults. The MBC intervention will be administered live, online via the free video conferencing platform, Zoom, to all eligible study participants enrolled in the active arms of the study. In addition to the 9-week, 9 session MBC class, referred to as "standard dose MBC" from here on out, investigators will also be testing a "low-dose MBC" version of the intervention, where each weekly session will run 1.5 hours in length rather than 2.5 hours. This is a 3-arm randomized controlled trial. The standard-dose and low-dose versions of the MBC intervention will be compared to a third arm of the study, a health education active control group. Members of the control group will be offered the MBC class upon completion of the research study. The Study Aims are to: (1) Evaluate feasibility and acceptability of MBC delivered in two online formats (standard dose vs. low dose). (2) Evaluate impacts of MBC standard-dose vs. MBC low-dose vs. health education control group on health conditions relevant for emerging adults, demonstrated to be influenced by MBC in a prior study, specifically depressive symptoms, loneliness, and sedentary activity. (3) Explore mechanisms by which MBC may exert effects on aforementioned health conditions, including interoceptive awareness, decentering, and perceived stress. Participant Population: young adults aged 18-29 years of age, residing in the United States who screen eligible will be invited to enroll. Students will be screened using a two-part process taking place online. Research assessments at baseline and 3-month will take place digitally using Qualtrics, LLC (Provo, UT, USA) survey management tool. Participants will be sent secure links via email that can be accessed with their participant identification number. Enrolled participants will be randomly assigned to one of three groups: (1) standard MBC; (2) low-dose MBC or (3) health education control group. The control group will be given the opportunity to participate in the intervention after the study MBC course is completed and follow-up assessments have been administered.


Study summary:

Study Design The methodological approach includes a 3-arm trial of MB-College (i.e., standard-dose vs. low-dose) vs. enhanced usual care waitlist control, with n=100 per arm All research assessments will take place digitally using Qualtrics, LLC (Provo, UT, USA) survey management tool. Participants will be sent secure links via email that can be accessed with their participant identification number. The MBC classes will be offered online via Zoom by a trained and certified MBC instructor. Baseline assessment links will be sent to all enrolled participants and completed within four weeks of the start of the interventions. A single follow-up survey, "the three month follow up" will occur at least one day after and up to five weeks after the end of the intervention (i.e. the Week 8 class). Staff will prioritize having participants complete the surveys within the first three weeks of the assessment window, but will allow for participants to complete up to five weeks after. Additionally, the study will accept online survey completed outside the official follow up window if needed. The total length of involvement for study participants will be around 3-4 months from the time of enrollment to the time of the final research assessment. The study interventions last 9 weeks and take place in the first two months for individuals in the standard-dose and low-dose intervention arms. Participant Recruitment: Participants will be recruited to participate in MBC primarily online using the following methods: (a) electronic distribution of the MBC advertisement cards via social media, such as Facebook, Twitter, Instagram, etc.; (b) emails sent to student listservs and through academic social networks;.(c) word of mouth through graduates of the MBC program and university staff interested in supporting the study; and (d) online information sessions offered by course instructor prior to the start of class. Inclusion of women and minority groups - efforts will be made to recruit both women and minority students by intentionally advertising for the study in locations where said populations congregate/have a presence. Randomized groups will attempt to be balanced on gender, race-ethnicity, and level of education. Screening Process Online Screening: Those who express interest in the study will complete an online screening assessment and availability form. Those who screen eligible based on the anonymous online screening (part 1 of 2) will be given the informed consent form online to read over and complete followed by an availability and contact form (part 2 of 2). Informed Consent Informed consent will be administered and collected using digital forms through Qualtrics, LLC (Provo, UT, USA) from interested students who have screened eligible based on the anonymous online screener (part 1 or 2). The digital signature and informed consent document will be kept on file in a secure locations separate from participant data. Randomization Process Participants will be randomly assigned to one of three groups: (1) the standard-dose MBC group; (2) the low-dose MBC group; or (3) the health education control group. A covariate adaptive randomization process will be used, balancing groups based on gender, race-ethnicity, and level of education. Assessment Overview: The following participant assessments will be administered to study participants: 1. Baseline Assessments -online baseline assessment will be completed within the four weeks leading up to the start of the online interventions. 2. 3-Month Follow Up Assessments - following the end of the nine-week interventions, participants will complete online follow up assessments similar to the assessments given at baseline. Measures Descriptions: 1. Demographics: age, race/ethnicity, socioeconomic status, education, sexual orientation and gender orientation, student status, and employment. 2. Childhood socioeconomic status: retrospective reporting of parents' education, based on standardized questionnaires used in the Atherosclerosis Risk in Communities (ARIC) study. 3. Treatment expectancy: 6-item Credibility/ Expectancy questionnaire. 4. Depressive symptomatology: Assessed using Center for Epidemiologic Studies Depression Scale Revised (CESD-R). The CESD survey has been used extensively in the epidemiologic literature to assess depressive symptomatology. The scale was updated to the CESD-R by Van Dam et al., which allows diagnosable criteria similar to Diagnostic and Statistical Manual (DSM) of Mental Disorders. 5. Anxiety: Assessed using the validated Generalized Anxiety Disorder 7-item (GAD-7) scale. 6. Adverse Childhood Experiences: Measured using the standardized Childhood Trauma Questionnaire (CTQ) and the Childhood Experiences of Care and Abuse Inventory neglect subscale. 7. Medication use: Assessed directly from participants' medication bottles and self-report using standardized forms, including medication name, dose, frequency of use, and reason of use. 8. Substance use: questions taken from the National College Health Assessment II. 9. Alcohol consumption: additional self-report standardized questions assessing current alcohol consumption taken from the Behavioral Risk Factor Surveillance Survey (BRFSS).8 10. Physical Activity: Self-report physical activity is assessed using the International Physical Activity Questionnaire (IPAQ). 11. Fruit and Vegetable Consumption: self-report standardized questions assessing current fruit and vegetable consumption taken from Harvard Food Frequency Questionnaire modified to 3-items. 12. Sleep: Sleep quality and duration is assessed using the validated Pittsburgh Sleep Quality Index (PSQI). 13. Mindfulness: Assessed using the validated Five Facet Mindfulness Questionnaire Short Form 15-items. 14. Perceived stress: Assessed using the validated 14-item Perceived Stress Scale. 15. Interoceptive awareness: Assessed using the validated Multidimensional Assessment of Interoceptive Awareness (MAIA-2). 16. Loneliness: Assessed using the validated R-UCLA Loneliness Scale. 17. Global Health: individual physical, mental and social health are measured using the validated NIH PROMIS Global Health v1.2 scale and PROMIS-29+2. 18. Mindfulness attendance and practice questions will be administered to intervention group participants at the time of the 3 month follow up to get at mindfulness exposure and dose. 19. Ecological Momentary Assessment-Stress: assessed using 3-item scale developed by Creswell et al 2019. Withdrawal during intervention Some amount of dropout during the study is anticipated, and therefore investigators may decide to over enroll in the waitlist group to account for this expected issue. If a participant in the intervention group decides to withdraw from the study during the MB-College course, they will be invited to still take part in the follow up assessments. Confidentiality Randomly generated participant identification numbers will be assigned to students who consent to data collection. All questionnaires and tasks will be completed under the assigned participant identification numbers. Consent forms and personal identifiable information will be kept separate and securely away from participant identification numbers in a secure digital file on closed network servers. Blinding All study staff will be blinded to the participant treatment allocation with the exception of the instructor and staff member coordinating participants within each course. All staff monitoring participant assessments and survey completion will be blinded to the participant treatment allocation to promote equipoise. Data analyses will be performed by a statistician blinded to treatment allocation type. The data manager will be able to break blinding if needed for safety. Circumstances for breaking the blind would be a large number of adverse experiences (>10% of enrolled participants reporting AEs rated as severe or life threatening) taking place in one or more study group. Acceptability Assessed via acceptability ratings using the validated Client Satisfaction Questionnaire (Cronbach's alpha=0.93), class attendance rates (proportion of eligible participants who complete MB-College, missing no more than 3 classes) and the Net Promoter Score. Feasibility Assessed via (a) participant recruitment rates, (b) participant retention rates, and (c) treatment fidelity assessments, via delivery of treatment per protocol (assessed via percent adherence of instructors to curriculum guide module), receipt of treatment (assessed by class attendance), and enactment of treatment skills (assessed by home practice completion, mindfulness levels). Ecological Momentary Assessments: A 3-item customized measure of stress will be administered using time contingent ecological momentary assessments. SMS will be administered using Qualtrics SMS service sent to participants' personal phones. The numbers will be loaded into Qualtrics de-identified using participant ID numbers. The SMS messaging will be 1 way with participants completing the survey through a mobile link. The survey will be sent at baseline and follow-up assessments every day for 1 week 4 times per day between 10:00 am and 11:00 pm. The survey as well as assessment schedule were tested in a randomized controlled trials (n=153) and the researchers who conducted the study advised on the implementation for this pilot study. Fidelity Monitoring: Intervention fidelity will be ensured by (1) rigorous, program specific training for the instructor with feedback, (2) recording of all sessions with a 10% quality audit reviewed with instructor after each cohort, (3) monitoring participant attendance, home practice of treatment skills, and understanding of skills, and (4) a comprehensive mixed methods approach (e.g. daily practice logs) for understanding of treatment enactment. Follow-up visits Follow-up surveys will be digitally distributed and completed within the pre-defined assessment windows previously outlined. Questionnaires and assessments administered at 3-months follow-up are identical to those administered at baseline with the exception that questionnaires for which the answers should not change or be informative (age, race/ethnicity, education, childhood socioeconomic status) are not given at follow-ups. In addition, adverse events are monitored and documented at each of the follow-up periods as well as throughout the duration of an individual's study involvement.


Criteria:

Inclusion Criteria: - 18-29 years of age - Able to read, write, and speak in English - Access to a computer, tablet, or smart phone device in order to complete online assessments and participate in the online interventions - Reside in the United States during the research study Exclusion Criteria: - Current, regular mindfulness meditation practice ≥1 time per week - Untreated, pre-existing mental health conditions, including borderline disorder, schizophrenia or psychosis, obsessive-compulsive disorder, panic attacks, alcohol or substance abuse, and eating disorders, who are not in regular care of a clinician. These participants are excluded as they may require additional or specialized treatment not able to be provided by the study or are already participating in practices similar to the intervention.


NCT ID:

NCT04733300


Primary Contact:

Principal Investigator
Eric B Loucks, PhD
Mindfulness Center at Brown University

MB-College Research Study
Phone: 4014004768
Email: mindfulness@brown.edu


Backup Contact:

Email: Frances_Saadeh@brown.edu
Frances B Saadeh, MPH
Phone: 4018636261


Location Contact:

Providence, Rhode Island 02912
United States

MB-College Research Study
Phone: 401-400-4768
Email: mindfulness@brown.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: June 12, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.